
Company profile · Onderzoeks- & kennisinstelling
Center for Microbiome Analyses and Therapeutics CMAT
- Research
- Onderzoeks- & kennisinstelling
- Leiden
- Research · Leiden
- Employees
- 11–50
- Province
- Zuid-Holland
- Country
- Netherlands
About Center for Microbiome Analyses and Therapeutics CMAT
The human microbiota, the collection of microorganisms in and on the human body, has been implicated in a wide variety of diseases, including infectious diseases, chronic inflammation, cancer and psychiatric disorders. The rapid advances in sequencing technology and associated computational methods facilitates assessment of the composition, function and activity of the human microbiome by studying their DNA (metataxonomics, metagenomics), RNA (metatranscriptomics), proteins (metaproteomics) and metabolites (metabolomics). By collaborating with various departments in and outside the LUMC, we aim to better understand the relation between the microbiome and human health and disease, which may eventually result in biomarker discovery and new prevention and treatment strategies for specific diseases.
Address
Headquarters
Albinusdreef 22333 LeidenZuid-Holland, Netherlands
Similar companies
Companies with a similar profile, Zuid-Holland first.

Microbiome Center
Hospital & Health Care · Den Haag
11–50 employeesView profile
Methylomics
Biotechnology · Rijswijk
2–10 employeesView profile

LUMC Global
Hospital & Health Care · Leiden
5,001–10,000 employeesView profile
Human Metabolome Technologies Europe B.V.
Biotechnology · Leiden
2–10 employeesView profile

CML Urban Research Leiden University
Research · Leiden
11–50 employeesView profile

MIMETAS
Biotechnology · Oegstgeest
51–200 employeesView profile